Morgan Stanley’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$41.2K Sell
9,821
-2,450
-20% -$10.3K ﹤0.01% 6421
2025
Q1
$58.5K Buy
12,271
+4,497
+58% +$21.5K ﹤0.01% 6216
2024
Q4
$29.6K Sell
7,774
-2,760
-26% -$10.5K ﹤0.01% 6452
2024
Q3
$94.4K Sell
10,534
-192
-2% -$1.72K ﹤0.01% 6030
2024
Q2
$104K Sell
10,726
-1,033
-9% -$10.1K ﹤0.01% 5943
2024
Q1
$159K Sell
11,759
-10,518
-47% -$143K ﹤0.01% 5801
2023
Q4
$244K Buy
22,277
+14,613
+191% +$160K ﹤0.01% 5870
2023
Q3
$78.5K Sell
7,664
-833
-10% -$8.53K ﹤0.01% 5990
2023
Q2
$134K Buy
8,497
+1,095
+15% +$17.3K ﹤0.01% 5814
2023
Q1
$167K Sell
7,402
-3,019
-29% -$68.3K ﹤0.01% 5790
2022
Q4
$372K Sell
10,421
-8,569
-45% -$306K ﹤0.01% 5385
2022
Q3
$740K Sell
18,990
-13,285
-41% -$518K ﹤0.01% 5061
2022
Q2
$1.55M Buy
32,275
+20,253
+168% +$971K ﹤0.01% 4716
2022
Q1
$1.11M Buy
12,022
+5,290
+79% +$489K ﹤0.01% 4914
2021
Q4
$1.5M Sell
6,732
-5,801
-46% -$1.29M ﹤0.01% 4787
2021
Q3
$4.34M Sell
12,533
-12,667
-50% -$4.39M ﹤0.01% 3891
2021
Q2
$9.47M Buy
25,200
+7,255
+40% +$2.73M ﹤0.01% 3053
2021
Q1
$5.57M Buy
17,945
+13,061
+267% +$4.06M ﹤0.01% 3294
2020
Q4
$1.22M Buy
4,884
+920
+23% +$230K ﹤0.01% 4541
2020
Q3
$732K Sell
3,964
-279
-7% -$51.5K ﹤0.01% 4426
2020
Q2
$1.06M Buy
4,243
+355
+9% +$88.8K ﹤0.01% 4127
2020
Q1
$704K Sell
3,888
-1,927
-33% -$349K ﹤0.01% 4181
2019
Q4
$2.42M Buy
5,815
+5,676
+4,083% +$2.37M ﹤0.01% 3882
2019
Q3
$35K Sell
139
-623
-82% -$157K ﹤0.01% 5845
2019
Q2
$302K Buy
762
+759
+25,300% +$301K ﹤0.01% 4844
2019
Q1
$2K Buy
+3
New +$2K ﹤0.01% 6451